Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest
The European Journal of Contraception & Reproductive Health Care, 06/30/09
Zeun S et al. - Treatment with an OC containing E2V and DNG was well tolerated and was associated with stable E2 concentrations over 28 days. The pharmacokinetics of DNG were consistent with previous findings. Minimum serum concentrations of DNG increased only slightly during phases of the regimen during which DNG was administered.
Related Articles
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis
International Journal of Gynecology & Obstetrics, 10/13/09
Relevance Score: 83%
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel
Contraception, 10/16/09
Relevance Score: 80%
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A
British Journal of Clinical Pharmacology, 12/11/09
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
Transplant Infectious Disease, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor